Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.02, read 2026-11-02
Ethical does not pass the values gate
Price32.48 USD
Fair value31.14
Ethical score70.0/100
Value readFairas of 4 Nov 2026
Our investment reviews on this name
2026-10-11Read Accumulation28.05+15.8% to today ✓Markdown gives way to Accumulation after a 10% slide in 9 weeks
2026-08-08Read Markdown31.15+4.3% to today Markup gives way to Markdown
2026-07-02Read Markup31.34+3.6% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
OUTFRONT Media Inc. holds its Accumulation at $32.48. Elevated stress, defensive posture warranted, held for 193 days.
As held on the ledger · 2026-11-04
Phase
Accumulation
Quantitative state
Elevated stress, defensive posture warranted, held for 193 days
Price at the screen
$32.48
Valuation
23.20 trailing · 21.41 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.54
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
77.77%
Below 33%
Interest-bearing debt is 77.8% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
8.77%
Below 49%
Money owed to the company is 8.8% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
OUTFRONT Media's business is in a permissible area, but its interest-bearing debt is about 78% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when OUT's ethical verdict changes
Today OUT does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 4 Nov 2026: it trades above our $31.14 fair value estimate, 13.50% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. The price runs 4.3% above the base estimate.
Third-party analyst targets. The average target sits +17% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Where our models see it going: fair-value estimate $31.14, with a range of $31.14 to $35.81, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Billboards draw eyes but fail the value test
Walk past any city bus shelter or highway gantry and you see the same thing: bright ads trying to catch commuters between stops. OUTFRONT Media runs thousands of those sites across the US, selling space to brands that still believe physical presence beats screens alone. Revenue is rising 10 percent and return on equity sits at 27 percent, yet the shares trade at 23.9 times forward earnings while our fair value sits 10 percent below the current price.
That gap leaves no margin of safety and earns the position a clear "none" rating. Profit margins remain stuck at 10 percent, the moat is unproven, and the business still depends on advertising budgets that can vanish when the economy softens. Analyst targets may sit higher, but our numbers do not support paying up today.
Ethical checks clear without issue, yet valuation discipline comes first. When price already exceeds what the cash flows justify, the story stays on the shelf regardless of the sector tailwinds. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
OUT trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Accumulation$32.48+0.4%Entry 17
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 93%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04Accumulation$32.36+1.1%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 93%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Accumulation$32.00+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 93%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Accumulation$32.00+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 93%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Accumulation$32.00+3.1%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 93%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Accumulation$31.03+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 93%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Accumulation$31.03+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 93%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Accumulation$31.03-0.5%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 93%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$31.18+5.1%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 93%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $36.
2026-10-18Accumulation$29.67+5.8%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 93%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $36.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
